Arrowhead Pharmaceuticals
ARWR
#1961
Rank
โ‚น1.005 T
Marketcap
โ‚น7,137
Share price
-0.78%
Change (1 day)
444.99%
Change (1 year)

EPS for Arrowhead Pharmaceuticals (ARWR)

EPS in 2025 (TTM): โ‚น30.11

According to Arrowhead Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is โ‚น33.33. an increase over its 2024 EPS that were of -โ‚น476.10.

EPS history for Arrowhead Pharmaceuticals from 1997 to 2025

Annual EPS

Year EPS Change
2025-โ‚น0.95-99.8%
2024-โ‚น476.10161.39%
2023-โ‚น182.1417.36%
2022-โ‚น155.2019.85%
2021-โ‚น129.5061.9%
2020-โ‚น79.98-216.67%
2019โ‚น68.56-210.77%
2018-โ‚น61.8938.3%
2017-โ‚น44.75-64.93%
2016-โ‚น127.59-16.25%
2015-โ‚น152.3528%
2014-โ‚น119.03-3.85%
2013-โ‚น123.79-31.58%
2012-โ‚น180.92331.82%
2011-โ‚น41.90-51.11%
2010-โ‚น85.70-79.07%
2009-โ‚น409.45-37.68%
2008-โ‚น657.02-16.87%
2007-โ‚น790.3338.33%
2006-โ‚น571.32122.22%
2005-โ‚น257.0942.11%
2004-โ‚น180.92533.33%
2003-โ‚น28.57-99.08%
2002-โ‚น3,09225%
2001-โ‚น2,47333.33%
2000-โ‚น1,855-120%
1999โ‚น9,275-400%
1998-โ‚น3,092-81.48%
1997-โ‚น16,694

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น831.88 2,396.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
-โ‚น776.04-2,428.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น599.89 1,700.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น360.88 982.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
-โ‚น274.23-922.86%๐Ÿ‡บ๐Ÿ‡ธ USA